UZGent — Ghent

Public research footprint of UZGent, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Acute Myeloid Leukemia · Myelodysplastic Syndrome With Excess Blasts-2 · Spinal Cord Injuries · Neisseria Gonorrhoeae Infection

Recently updated registry entries

NCT06652438 — Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or… (Recruiting)
NCT07223814 — Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by… (Recruiting)
NCT06739655 — Preoperative Radiation Therapy and Immediate Breast Reconstruction (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UZGent?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.